DK2419741T3 - Risikovurdering af antibiotikabehandling af patienter, der lider af primær ikke-infektiøs sygdom, ved bestemmelse af niveauet af procalcitonin - Google Patents

Risikovurdering af antibiotikabehandling af patienter, der lider af primær ikke-infektiøs sygdom, ved bestemmelse af niveauet af procalcitonin Download PDF

Info

Publication number
DK2419741T3
DK2419741T3 DK10717531T DK10717531T DK2419741T3 DK 2419741 T3 DK2419741 T3 DK 2419741T3 DK 10717531 T DK10717531 T DK 10717531T DK 10717531 T DK10717531 T DK 10717531T DK 2419741 T3 DK2419741 T3 DK 2419741T3
Authority
DK
Denmark
Prior art keywords
determining
infectious disease
risk assessment
antibiotic treatment
primary non
Prior art date
Application number
DK10717531T
Other languages
English (en)
Inventor
Andreas Bergmann
Joachim Struck
Original Assignee
Brahms Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40886944&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2419741(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Brahms Gmbh filed Critical Brahms Gmbh
Application granted granted Critical
Publication of DK2419741T3 publication Critical patent/DK2419741T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575Hormones
    • G01N2333/585Calcitonins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/32Cardiovascular disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/32Cardiovascular disorders
    • G01N2800/325Heart failure or cardiac arrest, e.g. cardiomyopathy, congestive heart failure

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK10717531T 2009-04-14 2010-04-14 Risikovurdering af antibiotikabehandling af patienter, der lider af primær ikke-infektiøs sygdom, ved bestemmelse af niveauet af procalcitonin DK2419741T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09157886 2009-04-14
PCT/EP2010/002279 WO2010118855A1 (en) 2009-04-14 2010-04-14 Risk assessment for antibiotics treatment in patients suffering from primary non-infectious disease by determining the level of procalcitonin

Publications (1)

Publication Number Publication Date
DK2419741T3 true DK2419741T3 (da) 2019-11-04

Family

ID=40886944

Family Applications (1)

Application Number Title Priority Date Filing Date
DK10717531T DK2419741T3 (da) 2009-04-14 2010-04-14 Risikovurdering af antibiotikabehandling af patienter, der lider af primær ikke-infektiøs sygdom, ved bestemmelse af niveauet af procalcitonin

Country Status (15)

Country Link
US (3) US9046532B2 (da)
EP (1) EP2419741B1 (da)
JP (1) JP5650718B2 (da)
CN (2) CN105334330A (da)
CY (1) CY1122202T1 (da)
DK (1) DK2419741T3 (da)
ES (1) ES2751105T3 (da)
HK (1) HK1221766A1 (da)
HR (1) HRP20191862T1 (da)
HU (1) HUE046182T2 (da)
LT (1) LT2419741T (da)
PL (1) PL2419741T3 (da)
PT (1) PT2419741T (da)
SI (1) SI2419741T1 (da)
WO (1) WO2010118855A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9488659B2 (en) 2012-04-12 2016-11-08 B.R.A.H.M.S. Gmbh Prognosis of adverse events in patients with suspected chronic heart failure
CN105528511A (zh) * 2014-10-25 2016-04-27 潘一琦 一种远程诊疗对比式问诊方法及其系统
CN107301319B (zh) * 2017-06-26 2021-02-26 济南市儿童医院 儿科临床及科研中抗菌药物使用危险评估系统
CN111656189A (zh) * 2017-12-20 2020-09-11 B.R.A.H.M.S有限公司 基于合并症患者的降钙素原的抗生素疗法指导
EP3502706A1 (en) * 2017-12-20 2019-06-26 B.R.A.H.M.S GmbH Workflow for risk assessment and patient management using procalcitonin and midregional-proadrenomedullin

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5314804A (en) * 1992-03-24 1994-05-24 Serim Research Corporation Test for Helicobacter pylori
DE19600875C1 (de) * 1996-01-12 1997-06-26 Brahms Diagnostica Gmbh Diagnostisches Verfahren zur Bestimmung der Ätiologie entzündlicher Prozesse
ATE395364T1 (de) * 1999-12-22 2008-05-15 Dade Behring Marburg Gmbh Gegen procalcitonin gerichtete antikörper, ihre herstellung und verwendung
WO2003016910A1 (en) * 2001-08-20 2003-02-27 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US20050148029A1 (en) * 2003-09-29 2005-07-07 Biosite, Inc. Methods and compositions for determining treatment regimens in systemic inflammatory response syndromes
DE102005034174A1 (de) * 2005-07-21 2007-02-08 B.R.A.H.M.S Ag Liquordiagnostisches in vitro Verfahren zur Diagnose von Demenz-Erkrankungen und neuroinflammatorischen Erkrankungen
FR2894675B1 (fr) * 2005-12-14 2008-06-27 Assist Publ Hopitaux De Paris Distinction des meningites bacteriennes et virales
DE102006046996A1 (de) * 2006-10-01 2008-04-03 Brahms Aktiengesellschaft Diagnose von Infektionen oder Entzündungserkrankungen der Atemwege und Lunge assoziiert mit Herzinsuffizienz
CN110346577A (zh) 2007-08-03 2019-10-18 B.R.A.H.M.S 有限公司 降钙素原(pct)在患原发性非传染疾病的患者的风险分级和预后中的应用

Also Published As

Publication number Publication date
CN102395888A (zh) 2012-03-28
CN102395888B (zh) 2017-05-03
JP5650718B2 (ja) 2015-01-07
CY1122202T1 (el) 2020-11-25
CN105334330A (zh) 2016-02-17
WO2010118855A1 (en) 2010-10-21
HUE046182T2 (hu) 2020-02-28
HK1221766A1 (zh) 2017-06-09
US20120100635A1 (en) 2012-04-26
ES2751105T3 (es) 2020-03-30
PL2419741T3 (pl) 2020-01-31
JP2012523573A (ja) 2012-10-04
US9810699B2 (en) 2017-11-07
US20180052179A1 (en) 2018-02-22
HRP20191862T1 (hr) 2019-12-27
PT2419741T (pt) 2019-11-04
US9046532B2 (en) 2015-06-02
LT2419741T (lt) 2019-11-11
EP2419741B1 (en) 2019-07-31
US20150247871A1 (en) 2015-09-03
SI2419741T1 (sl) 2019-12-31
EP2419741A1 (en) 2012-02-22

Similar Documents

Publication Publication Date Title
LTC2785706I2 (lt) Pakeistieji 4-fenil-piridinai, skirti su nk-receptoriumi susijusių ligų gydymui
DK2477592T3 (da) Rollatorkørestol
DK2222272T3 (da) Behandling af luftvejssygdom
BR112012020050A8 (pt) acessório ocular iluminado
DK2540238T3 (da) Specialbyggede patientspecifikke ortopædiske stiftføringer
BRPI0908026A2 (pt) Métodos para o tratamento de doenças do intestino
DK3192520T3 (da) Terapeutiske midler til reducering af niveauerne af parathyreoideahormon
DK2488242T3 (da) Medicinsk indåndingsmaske
ZA201403549B (en) Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for use in therapy of an acute disease or acute condition of a patient for stabilizing the circulation
DK2627345T3 (da) Formuleringer til behandling af sygdomme i de øvre luftveje
BR112012000502A2 (pt) terapia de combinação para o tratamento de diabetes
IT1403453B1 (it) Protesi retinica
BRPI1006504A2 (pt) fralda descartavel
DK2903629T3 (da) Antistofkonjugat til anvendelse ved behandling af inflammatorisk tarmsygdom
BRPI1007478A2 (pt) indicação de filiação de csg
BRPI1011535A2 (pt) tratamento de distúrbios resistentes à insulina.
HK1221766A1 (zh) 通過測定降鈣素原水平對在原發性非感染性疾病患者中的抗生素治療進行風險評估
EP2563395A4 (en) TREATMENT WITH ANTI-S1P ANTIBODY OF PATIENTS WITH OCULAR DISEASES
EP2544686A4 (en) COMBINED METHODS FOR THE TREATMENT OF DISEASES
DK2323686T3 (da) Adiponectin til behandling af lungesygdom
BR112014011898A2 (pt) métodos e composições para o tratamento de diabetes e sintomas relacionados
BRPI0913939A2 (pt) dose unitária de apadenoson
DK2440170T3 (da) Kørestol med forbedret manøvrerbarhed for halvsidigt lammede personer
FR2958757B1 (fr) Lunettes de correction de couleur
EP2483860A4 (en) RISK COST ANALYSIS OF A CURRENCY TRANSFER REDUCTION TO MANAGE CURRENCY TRANSLATIONS